Most Viewed Virtual Trip Videos
Search the Virtual Trip
Psychedelic Science 2025
See our latest video selection from PS2025 from July, 2025 in Denver Colorado.
In 2025 it will be 20 years since the Centre for Psychedelic Research began its study of psychedelic drugs in humans, first at Bristol University and then since 2008 at Imperial College London. What started out as an imaging study of the brain mechanisms of psilocybin in collaboration with Robin Carhart-Harris and Amanda Feilding has turned into a life changing body of research that has encompassed many hundreds of colleagues: doctors psychologists and neuroscientists.
David Nutt
A growing number of professional athletes are turning to psychedelics, not for performance enhancement, but for healing, reflection, and deeper self-understanding.
Aubrey Marcus, Jordan Poyer, Jon Feliciano, and Robert Gallery
The momentum behind psychedelic policy reform has surged over the past five years—especially within state legislatures. With over 220 bills introduced across 38 states and D.C. since 2020, the field is evolving rapidly. But sustained progress requires a clearer understanding of what’s working—and what’s not.
Sam Chapman
In the 1980s the German mycologist Jochen Gartz published a series of provocative scientific papers that detailed a process for introducing synthetic tryptamines into the substrate of Psilocybe cubensis leading to the growth of mushrooms with an unprecedented concentration of psilocin. This presentation represents the results of the first effort to reproduce Gartz's research with quantitative chemical analysis.
Hamilton Morris
Watch for hot-off-the-press public opinion research on Americans’ beliefs, understanding, and policy support around psychedelics.
Abel Gustafson, Matt Goldberg
Ketamine has surged to the forefront of psychedelic medicine and pop culture alike ,but alongside the accolades is a growing shadow.
Hamilton Morris, Liana Gillooly, Gita Vaid
As interest in psychedelic therapies grows, the conversation needs to shift from promise to practice. This panel brings together voices with unique perspectives to engage with some of the most important questions of the moment.
Shereef Elnahal, Krista Tippett, Amelia Bergman, Rachel Yehuda
This special conversation with Dr. Marketa Wills, the new CEO and Medical Director of the American Psychiatric Association, explores the potential for the community and institutions of psychiatry to integrate the findings of the last decade of psychedelic research, and prepare for new therapeutic treatments that may become available in the next few years.
Marketa Wills, Tyler Norris, Jessica Punzo
What happens when psychedelic insight meets cosmic data, and sound becomes a tool for transformation? Dr. Scott Bolton, lead scientist on NASA’s Juno Mission, joins Grammy-nominated artists Maejor and Vic Mensa to explore how altered states, planetary frequencies, and spiritual practices shape their creative work.
Devon Phillips, Maejor Green, Vic Mensa, Scott Bolton
A lively, fun and freewheeling conversation about psychedelics in creating art and facilitating healing featuring My Morning Jacket lead singer Jim James, and comedian/psychonaut Reggie Watts hosted by writer/producer Donick Cary (The Simpsons, Have a Good Trip: Adventures in Psychedelics)
Donick Cary, Reggie Watts, Jim James
his opening performance and collective ceremony invites attendees to center and ground themselves in the meaning and purpose of Juneteenth as they move throughout the rest of the conference. Together, we honor the millions harmed by the transatlantic slave trade, and celebrate the still-to-be-realized promise of freedom that Juneteenth represents.
Hanifa Nayo Washington, Pamela Roundtree
In celebration of Juneteenth, this special opening panel features racial justice activists, criminal and juvenile legal system reform advocates, and visionary leaders in the fight for Black liberation and healing. Panelists will explore socioeconomic and race-based trauma in the US and the role of innovation, Black leadership, and psychedelics in healing that trauma.
Sutton King, Kempis Songster, Makaya Kelday-Judah, Harry Grammer, Ph.D., Reggie Harris
As identical twin sisters that experienced sexual, physical, and emotional childhood abuse everyday for over 10 years—and developed identical coping mechanisms that evolved into food addictions—the Quann sisters know firsthand just how seminal psychedelics can be to trauma and healing journeys.
Cipriana Quann, TK Quann, Vicky Dulai
It was not so long ago that psychedelic researchers struggled for public support and alliances. Now, numerous high-profile political leaders are eager to develop psychedelic science programs in their states. In this unique session, we will hear from two sets of scientists and political allies who advocate for expanding psychedelic research in their states.
Sue Sisley, MD, Kyrsten Sinema, Tim Ryan, Krista Tippett, Alan Davis
What if psychedelics could help the brain relearn how to learn? Dr. Gül Dölen shares her groundbreaking research on how psychedelic compounds can reopen “critical periods” of brain plasticity.
Gül Dolen, Amy Emerson
This special conversation between Oprah Daily Editorial Director Pilar Guzman and Krista Tippett explores the ways in which psychedelics can help women reckon with the cultural constraints around womanhood at every stage of life– but especially its second half.
Pilar Guzmán, Krista Tippett
In this keynote, Dr. Anthony Estreet makes the case social workers are essential to the future of equitable psychedelic care.
Tyler Norris, Anthony Estreet
In this Keynote we will take a close look at some of the remarkable results of the large Lykos MDMA Study for PTSD which showed that MDMA opens traumatized people up to experience themselves with a deep sense of compassion and kindness.
Bessel van der Kolk
Paul's talk is a deep dive into psilocybin mushrooms, their past, present and future uses.
Paul Stamets
Within the last decade, we have witnessed a remarkable shift in cultural perceptions and narratives with respect to psychedelics. Once vilified and prohibited, psychedelics are now being hailed as catalysts for a new revolution in mental health care – even as they remain largely prohibited on the federal level.
Dennis McKenna
fter a week of deep learning, connection, and exploration, this final session brings us back together to reflect on where we’ve been and where we’re going.
Ismail Lourido Ali, Betty Aldworth
The official Opening Plenary of Psychedelic Science 2025. This 90-minute session brings the full community together to mark the start of the conference. No other programming is scheduled during this time—we invite everyone to be part of this collective moment.
Rick Williams, Ismail Lourido Ali, Betty Aldworth, Rick Doblin, Vicky Dulai
As interest in group psychedelic-assisted therapy grows, researchers are exploring diverse protocols, populations, and psychedelic medicines to enhance therapeutic outcomes and accessibility. This panel brings together experts conducting groundbreaking studies on group-based psychedelic therapy, offering insights into how different approaches can foster healing, connection, and transformation.
Chris Stauffer, Jae Sevelius, Anthony Back
Oregon and Colorado have pioneered and iterated on the first state-regulated psychedelics markets. But there are many additional ways beyond the Oregon and Colorado models to establish a market.
Leonard Gilroy, Barine Majewska, Courtney Barnes, Jared Moffat, Allison Hoots
As global momentum builds around psychedelic reforms, the United Nations’ Common Position on Drug Policy offers a critical framework for shaping a humane, rights-based approach to this issue on the international stage. This panel will explore how the UN’s focus on public health, human rights, and sustainable development can support decriminalization efforts, while aligning with the goals of the 2030 Agenda for Sustainable Development.
Jorge Valderrábano
Advancing Research
Discover the cutting-edge studies, molecular insights, and clinical breakthroughs that are propelling psychedelic science into a new era.
Don’t miss the most talked-about presentations and conversations from leading voices—these standout sessions capture big ideas, cultural shifts, and unforgettable moments from Psychedelic Science.
Psychedelic Science 2023 features opening land acknowledgement and addresses by Rick Doblin, Governor Rick Perry, and Governor Jared Polis.
Gov. Rick Perry, Governor Jared Polis, Maya Padilla
Key themes at Psychedelic Science 2023 included examining access, affordability, and reciprocity. The community was urged to address the impact of colonial systems on Indigenous communities and ensure equity for
Marwan and Noam, Snow Raven
Dr. Smith and Dr. Jones explore advances in renewable energy technologies at the CleanTech Conference, focusing on solar and wind innovations.
Tim Ferris
Michael Pollan, an influential author, sparked interest in psychedelic research with his book "How to Change Your Mind." Bob Jesse, a key figure in the resurgence of psychedelics, has made
Robert Jesse, Michael Pollan
Blake Mycoskie founded TOMS Shoes with the One for One® model, providing shoes to children in need globally. He also co-founded Madefor to promote positive habits and practices.
Joe Green, Blake Mycoskie
Colorado becomes first state to regulate access to psilocybin, ayahuasca, mescaline, and ibogaine after passing Natural Medicine Health Act. Christiana Musk interviews Senate President Fenberg on implications and challenges.
Christiana Musk, Steve Fenberg
For entrepreneurs, investors, and researchers, this curated selection spotlights funding trends, clinical breakthroughs, and entrepreneurial case studies that are fueling a rapidly evolving sector.
Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.
Sandy Samberg
Building better business can drive change, improve social outcomes, and regenerate the environment. Learn from successful individuals who have integrated principles into their company operations for global impact.
David Champion
Vicky Dulai of Compassion For Addiction moderates a discussion with Amy Emerson of MAPS Public Benefit Corporation and Rachel Yehuda of Icahn School of Medicine on leadership in the psychedelic
Rachel Yehuda
Hardman provides a quick overview of the emerging psychedelic sector, covering financial, research, and policy landscapes with data visuals. He also explores unanswered questions about the sector's future.
Josh Hardman
MDMA-assisted therapy (MDMA-AT) shows promise in treating PTSD and comorbid eating disorders. A study found significant reductions in eating disorder symptoms with MDMA-AT compared to placebo in severe PTSD patients.
Adele LaFrance, Timothy Brewerton
Psilocybin therapy tested for safety, feasibility, and efficacy in cancer patients with major depressive disorder, using group treatment in a cancer center setting. Clinical trial details: NCT04593563.
Betsy Jenkins
Delve into the policy debates, social justice initiatives, and harm reduction strategies driving legislative change—get inspired by visionary approaches that are rewriting the rules of access and equity.
Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.
Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd
Address delves into peyote's historical, cultural, and colonial impact, challenging dominant narratives and exploring paths for cultural preservation and religious freedom. Speakers illuminate untold narratives and complexities.
Discussion between experts on pragmatic frameworks, demographic considerations, and evidence-based practices shaping psychedelic policy reform for diverse contexts, addressing regulatory challenges and fostering nuanced understanding.
Tatiana Quintana, Melissa Lavasani, Logan Davidson
Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case
Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper
Panel of experts explores psychedelics' role in conflict resolution, restorative justice, and peace-building. Discussion includes research, experiences, and ethical considerations for integrating psychedelics into transformative processes.
Young elders explore merging tradition and modernity, addressing political, ecological, and epistemological challenges. Discussion aims to balance tradition and progress in a changing world.
Charlotte James
Whether you’re a clinician, practitioner-in-training, or simply curious about therapeutic models, this playlist equips you with real-world insights, safety protocols, and ethical considerations for responsible integration.
Dr. Anne Wagner and Dr. Michael Mithoefer discuss therapeutic potential of MDMA for couples, sharing insights from their MDMA-assisted couples therapy trials and ongoing research with Dr. Chandra Khalifian and
Chandra Khalifian, Leslie Morland, Kayla Knopp
MAPS completes Phase 3 study for MDMA-AT in PTSD treatment, marking historic milestone in psychedelic drug research. Safety and efficacy of MDMA-assisted therapy still under investigation.
Keren Tzarfaty, Michael Mithoefer, Julie Holland
Therapists and clinicians must collaborate to integrate psychedelic therapy into the behavioral health system, engaging professional organizations, providers, payers, and policymakers. Key steps for integration and clinician involvement will be
David Esselman, Sarah Abedi
Panel explores challenges of managing expectations and risks in psychedelic-assisted therapy amid growing media coverage. Participants, patients, and practitioners often lack information on risks.
David B Yaden, Xiaojue Hu
Therapists and religious professionals discuss ethical considerations in using psychedelics with vulnerable individuals, emphasizing the need for integrity and accountability in the psychedelic profession.
Cedar Barstow, Jennifer C Jones
Session explores health equity challenges and opportunities in mainstream psychedelic therapy, focusing on experiences of 3 women of color. Topics include overcoming inequity, cultural trauma, power dynamics, and ancestral healing.
Claudia Cuentas, Sara Reed, Deran Young
Psychedelic-assisted therapies for adolescents are discussed, including the use of ketamine for treatment-resistant depression and the need for further studies and careful consideration of risks. Traditional use of plant medicines
Corine de Boer, Rebecca Kronman, Glauber Assis
Changing Policy
Chart the evolving laws, social justice movements, and harm-reduction strategies that are reshaping access to psychedelics.
Dive into initiatives ensuring that psychedelic therapies reach underserved communities with respect and fairness.
Session explores health equity challenges and opportunities in mainstream psychedelic therapy, focusing on experiences of 3 women of color. Topics include overcoming inequity, cultural trauma, power dynamics, and ancestral healing.
Claudia Cuentas, Sara Reed, Deran Young
Psychedelic-assisted therapies for adolescents are discussed, including the use of ketamine for treatment-resistant depression and the need for further studies and careful consideration of risks. Traditional use of plant medicines
Corine de Boer, Rebecca Kronman, Glauber Assis
Young elders explore merging tradition and modernity, addressing political, ecological, and epistemological challenges. Discussion aims to balance tradition and progress in a changing world.
Charlotte James
Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case
Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper
Panel explores challenges of managing expectations and risks in psychedelic-assisted therapy amid growing media coverage. Participants, patients, and practitioners often lack information on risks.
David B Yaden, Xiaojue Hu
Understand how environmental, cultural, and indigenous rights inform policy on a worldwide scale.
Indigenous plant medicines and practices are threatened by colonialism, extraction, and climate change. Supporting traditional Indigenous Medicine conservation directly supports climate and biodiversity conservation.
Miriam Volat, Mona Polacca, Chief Nixiwaka Biraci Yawanawa
Traditional Indigenous medicines like Ayahuasca have become global phenomena. Psychedelic companies are exploring them for drug development, posing challenges for Indigenous and ceremonial communities.
Vicky Dulai of Compassion For Addiction moderates a discussion with Amy Emerson of MAPS Public Benefit Corporation and Rachel Yehuda of Icahn School of Medicine on leadership in the psychedelic
Rachel Yehuda
Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.
Sandy Samberg
Address delves into peyote's historical, cultural, and colonial impact, challenging dominant narratives and exploring paths for cultural preservation and religious freedom. Speakers illuminate untold narratives and complexities.
Learn the strategies and ethics behind safe, equitable, and community-centered psychedelic use.
Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case
Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper
Panel of experts explores psychedelics' role in conflict resolution, restorative justice, and peace-building. Discussion includes research, experiences, and ethical considerations for integrating psychedelics into transformative processes.
Traditional Indigenous medicines like Ayahuasca have become global phenomena. Psychedelic companies are exploring them for drug development, posing challenges for Indigenous and ceremonial communities.
Session explores health equity challenges and opportunities in mainstream psychedelic therapy, focusing on experiences of 3 women of color. Topics include overcoming inequity, cultural trauma, power dynamics, and ancestral healing.
Claudia Cuentas, Sara Reed, Deran Young
Traditional medicines and indigenous communities attract outsiders, but interactions can unintentionally harm. How can outsiders respectfully engage and contribute to traditional cultures?
Sandor Iron Rope, Claude Guislain, Sutton King
From ballot initiatives to state legislatures—see who’s writing the next chapter of psychedelic policy.
Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.
Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd
Discussion between experts on pragmatic frameworks, demographic considerations, and evidence-based practices shaping psychedelic policy reform for diverse contexts, addressing regulatory challenges and fostering nuanced understanding.
Tatiana Quintana, Melissa Lavasani, Logan Davidson
Address delves into peyote's historical, cultural, and colonial impact, challenging dominant narratives and exploring paths for cultural preservation and religious freedom. Speakers illuminate untold narratives and complexities.
Colorado becomes first state to regulate access to psilocybin, ayahuasca, mescaline, and ibogaine after passing Natural Medicine Health Act. Christiana Musk interviews Senate President Fenberg on implications and challenges.
Christiana Musk, Steve Fenberg
Young elders explore merging tradition and modernity, addressing political, ecological, and epistemological challenges. Discussion aims to balance tradition and progress in a changing world.
Charlotte James
Building better business can drive change, improve social outcomes, and regenerate the environment. Learn from successful individuals who have integrated principles into their company operations for global impact.
David Champion
Evolving Education
From specialist training to public outreach, see how learning about psychedelics is adapting to new needs, technologies, and audiences.
Equip yourself with evidence-based protocols, ethical frameworks, and hands-on approaches for therapeutic practice.
Therapists and clinicians must collaborate to integrate psychedelic therapy into the behavioral health system, engaging professional organizations, providers, payers, and policymakers. Key steps for integration and clinician involvement will be
David Esselman, Sarah Abedi
Dr. Anne Wagner and Dr. Michael Mithoefer discuss therapeutic potential of MDMA for couples, sharing insights from their MDMA-assisted couples therapy trials and ongoing research with Dr. Chandra Khalifian and
Chandra Khalifian, Leslie Morland, Kayla Knopp
Psychedelic-assisted therapies for adolescents are discussed, including the use of ketamine for treatment-resistant depression and the need for further studies and careful consideration of risks. Traditional use of plant medicines
Corine de Boer, Rebecca Kronman, Glauber Assis
Clinical trials show potential of psychedelics for psychiatric treatment, but studies note varied responses. Unclear clinical mechanism discussed in talk on neurobiology and optimizing psychedelic therapy.
Panel explores challenges of managing expectations and risks in psychedelic-assisted therapy amid growing media coverage. Participants, patients, and practitioners often lack information on risks.
David B Yaden, Xiaojue Hu
Ground your understanding in respect for diverse traditions, informed consent, and justice-oriented pedagogy.
Therapists and religious professionals discuss ethical considerations in using psychedelics with vulnerable individuals, emphasizing the need for integrity and accountability in the psychedelic profession.
Cedar Barstow, Jennifer C Jones
Traditional medicines and indigenous communities attract outsiders, but interactions can unintentionally harm. How can outsiders respectfully engage and contribute to traditional cultures?
Sandor Iron Rope, Claude Guislain, Sutton King
Session explores health equity challenges and opportunities in mainstream psychedelic therapy, focusing on experiences of 3 women of color. Topics include overcoming inequity, cultural trauma, power dynamics, and ancestral healing.
Claudia Cuentas, Sara Reed, Deran Young
Panel of experts explores psychedelics' role in conflict resolution, restorative justice, and peace-building. Discussion includes research, experiences, and ethical considerations for integrating psychedelics into transformative processes.
Young elders explore merging tradition and modernity, addressing political, ecological, and epistemological challenges. Discussion aims to balance tradition and progress in a changing world.
Charlotte James
Explore the tools, platforms, and funding models that are expanding how and where psychedelic education happens.
Hardman provides a quick overview of the emerging psychedelic sector, covering financial, research, and policy landscapes with data visuals. He also explores unanswered questions about the sector's future.
Josh Hardman
Indigenous plant medicines and practices are threatened by colonialism, extraction, and climate change. Supporting traditional Indigenous Medicine conservation directly supports climate and biodiversity conservation.
Miriam Volat, Mona Polacca, Chief Nixiwaka Biraci Yawanawa
Panel explores challenges of managing expectations and risks in psychedelic-assisted therapy amid growing media coverage. Participants, patients, and practitioners often lack information on risks.
David B Yaden, Xiaojue Hu
Manoj Doss discusses psychedelic impact on episodic memories, highlighting FLUX theory. Fred Barrett explores psychedelic therapy's potential for lasting shifts in psychological and cognitive flexibility across disorders.
Frederick Barrett, Manoj K. Doss
Capture the most inspiring moments and conversations that are bringing psychedelics into mainstream discussion.
Psychedelic Science 2023 features opening land acknowledgement and addresses by Rick Doblin, Governor Rick Perry, and Governor Jared Polis.
Gov. Rick Perry, Governor Jared Polis, Maya Padilla
Key themes at Psychedelic Science 2023 included examining access, affordability, and reciprocity. The community was urged to address the impact of colonial systems on Indigenous communities and ensure equity for
Marwan and Noam, Snow Raven
Dr. Smith and Dr. Jones explore advances in renewable energy technologies at the CleanTech Conference, focusing on solar and wind innovations.
Tim Ferris
Michael Pollan, an influential author, sparked interest in psychedelic research with his book "How to Change Your Mind." Bob Jesse, a key figure in the resurgence of psychedelics, has made
Robert Jesse, Michael Pollan
Blake Mycoskie founded TOMS Shoes with the One for One® model, providing shoes to children in need globally. He also co-founded Madefor to promote positive habits and practices.
Joe Green, Blake Mycoskie
Vicky Dulai of Compassion For Addiction moderates a discussion with Amy Emerson of MAPS Public Benefit Corporation and Rachel Yehuda of Icahn School of Medicine on leadership in the psychedelic
Rachel Yehuda
Become a MAPS Member with a monthly donation
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
